BCHE and early-onset autosomal dominant Alzheimer disease: Obviously, polypharmacology also implies various side-effects, as was noticed by an anonymous reviewer [22]; however, carbamate or amide-like molecules are attractive research aims to be studied by medicinal chemists; for instance, as potential cholinesterase inhibitors (ChEIs) that are used in Alzheimer’s disease (AD) pharmacotherapy [23,24,25].